Nasal Polyps
Nasal polyps are benign, soft, painless, oedematous protrusions of the nasal and paranasal sinus mucosa. They are most often a manifestation of chronic rhinosinusitis with nasal polyps (CRSwNP). They commonly arise around the middle meatus and ethmoidal sinuses, and are usually bilateral, pale, translucent, mobile, and insensitive to touch. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 1085
CT appearance of bilateral nasal polyposis. - Goldman-Cecil Medicine, p. 4169
Epidemiology
Nasal polyps are found in about 1% to 4% of adults and are uncommon in children. They occur more often in men, usually develop in adulthood, and tend to follow a chronic relapsing course. In a child, their presence should prompt assessment for disorders such as cystic fibrosis and, where appropriate, exclusion of congenital lesions such as meningocele or encephalocele. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 1085; Bailey and Love's Short Practice of Surgery, p. 793
Etiology and associations
The exact cause is not fully understood. Polyps result from persistent inflammation, mucosal oedema, and abnormal interaction between sinonasal epithelium and immune cells. Most CRSwNP has a type 2 inflammatory pattern involving IL-4, IL-5, IL-13, IgE, and eosinophils.
Important associations include:
- Chronic rhinosinusitis
- Asthma
- Aspirin or NSAID-exacerbated respiratory disease, formerly called Samter triad
- Allergic fungal rhinosinusitis
- Cystic fibrosis
- Eosinophilic granulomatosis with polyangiitis
- Occasionally, allergy and infection as contributing factors
A minority have a neutrophil-predominant, IL-17-mediated inflammatory pattern. - Goldman-Cecil Medicine, p. 4169
Pathology
Grossly, nasal polyps resemble pale grey, glistening, grape-like masses. Microscopically, they consist of loose oedematous connective tissue containing inflammatory cells and fluid, usually covered by pseudostratified ciliated columnar respiratory epithelium. Eosinophils are prominent in the common type 2 inflammatory form. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 1085
Clinical features
Small polyps can be asymptomatic. Larger polyps commonly cause:
- Progressive bilateral nasal obstruction or congestion
- Persistent watery rhinorrhoea or postnasal drip
- Reduced smell, hyposmia, or complete loss of smell
- Mouth breathing, snoring, and disturbed sleep
- Dull facial pressure or headache
- Visible pale mass at the nostril in advanced cases
- Recurrent or persistent sinus symptoms
Benign polyps do not usually bleed. Epistaxis, marked pain, facial swelling, eye symptoms, or a unilateral mass should raise concern for another diagnosis. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 1085
Diagnosis
Diagnosis is based on history and nasal examination, ideally with nasal endoscopy. Endoscopy shows pale, smooth, translucent masses, usually arising from the middle meatus. CT of the nose and paranasal sinuses demonstrates the extent of polyps, sinus disease, and anatomy before surgery.
Chronic rhinosinusitis is diagnosed when symptoms such as nasal blockage or discharge, with or without facial pressure and loss of smell, persist along with endoscopic evidence of polyps or characteristic CT changes. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 1085
Differential diagnosis
A unilateral nasal mass is not assumed to be a simple inflammatory polyp until other causes are excluded. Differential diagnoses include:
- Antrochoanal polyp
- Inverted papilloma
- Allergic fungal rhinosinusitis
- Malignancy of the nose or paranasal sinuses
- Meningoencephalocele in children
- Foreign body or granulomatous disease
Early biopsy or histopathology is advised for unilateral, bleeding, atypical, or suspicious lesions. - Goldman-Cecil Medicine, p. 4169; Bailey and Love's Short Practice of Surgery, p. 793
Treatment
Treatment aims to improve nasal airflow and smell, control inflammation, reduce polyp size, treat associated disease, and prevent recurrence.
-
Saline irrigation
Regular saline nasal washes help clear mucus and improve delivery of topical medicines.
-
Intranasal corticosteroids
These are first-line long-term therapy. They reduce nasal blockage, secretions, sneezing, polyp size, and may improve smell. Benefit generally requires several weeks of regular use. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, pp. 331-332
-
Short course of oral corticosteroids
Oral corticosteroids can give rapid improvement in severe obstruction and loss of smell, but benefit may be temporary and repeated courses carry important adverse effects. They should be prescribed only under clinician supervision. - Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 332
-
Management of associated conditions
Asthma, aspirin sensitivity, allergic fungal disease, and cystic fibrosis should be identified and managed. Aspirin desensitisation may help selected patients with aspirin-exacerbated respiratory disease.
-
Endoscopic sinus surgery
Functional endoscopic sinus surgery with polypectomy is indicated when symptoms remain troublesome despite appropriate medical therapy, when sinus drainage needs restoration, or when diagnosis is uncertain. Surgery improves symptoms but does not remove the inflammatory tendency, so recurrence is common. Topical nasal steroids after surgery reduce recurrence. - Goldman-Cecil Medicine, p. 4169; Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, p. 332
-
Biologic therapy
For severe uncontrolled CRSwNP despite standard treatment, particularly with type 2 inflammation and asthma, specialist-directed biologics such as dupilumab, omalizumab, or mepolizumab may reduce polyp burden, symptoms, systemic steroid use, and need for surgery. A recent
network meta-analysis supports efficacy of biologics, though the best choice depends on the patient’s inflammatory profile, asthma, prior surgery, cost, and access.
Complications and prognosis
Nasal polyps can substantially impair quality of life through chronic obstruction, anosmia, poor sleep, recurrent sinus symptoms, and asthma exacerbation. They are benign but frequently recur, even after surgery. Therefore, long-term follow-up and continued intranasal corticosteroid therapy are important.
Conclusion
Nasal polyps are usually bilateral benign inflammatory lesions associated with chronic rhinosinusitis. The usual presentation is persistent nasal obstruction with loss of smell. Nasal endoscopy and CT establish the diagnosis and extent. Regular intranasal corticosteroids are the foundation of treatment; short systemic steroid courses, endoscopic sinus surgery, and biologics are reserved for selected persistent or severe disease. Unilateral or bleeding polyps require urgent specialist evaluation to exclude fungal disease, inverted papilloma, or malignancy.